Severe Covid More Than Doubles Patient’s Risk Of Dying Inside A Year
In other sobering covid research news, scientists have found infections can cause long-term impacts to the brain. But AstraZeneca announced a lab study of its antibody drug Evusheld worked against the omicron variant of covid, and a separate study suggests shark antibodies may be useful in the battle against the virus.